Gracell Biotechnologies Inc. is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors.
View Top Employees from Gracell Biotechnologies| Website | https://www.gracellbio.com/ |
| Ticker | GRCL |
| Revenue | $54 million |
| Funding | $405.1 million |
| Employees | 43 (43 on RocketReach) |
| Founded | 2017 |
| Address | Building 12 Block B Phase Ii Biobay Industrial Park 218 Sangtian Street Suzhou Industrial Park, Suzhou, Jiangsu 215123, CN |
| Phone | +86 512 6262 6701 |
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Therapeutic Devices |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies |
Looking for a particular Gracell Biotechnologies employee's phone or email?
Gracell Biotechnologies Questions
The Gracell Biotechnologies annual revenue was $54 million in 2024.
Kevin Xie is the CFO of Gracell Biotechnologies.
43 people are employed at Gracell Biotechnologies.
Gracell Biotechnologies is based in Suzhou, Jiangsu.
The NAICS codes for Gracell Biotechnologies are [541, 54171, 5417, 54, 541713].
The SIC codes for Gracell Biotechnologies are [873, 87].
Top Gracell Biotechnologies Employees
-
35+
-
1
-
ViewYufei Xiang
Vice President Clinical and Operations at Gracell Biotechnologies
Philadelphia, PA, US5 -
ViewXinxin Wang
Research And Development, Project Leader and VP at Gracell Biotechnologies
San Diego, California, United States52 -
ViewXinzhao Jiang
Vice President, Head of US Regulatory Affairs at Gracell Biotechnologies
Los Angeles, California, United States3 -
1
Related Companies
